Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

Prostate cancer (PCa) is a disease that exhibits het- in terms of its clinical behavior [1]. There- , it is not surprising that heterogeneity also affects way we treat PCa. treatments such as radical prostatectomy (RP) radiation therapy (RT) have for years been consid- the standard of care for most men with non-meta- PCa [2,3]. During the last 120 years, many changes surgical and radiation techniques have arose reduce morbidity and improve oncological and func- outcomes [4]. However, despite all of the effort these advances, the negative effects on sexual, and bowel function remain unsolved [5].